NKG2D CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKG2D CAR-T cells, covering 2025-06-15 to 2025-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial [Phase 1]